Laboratories) both times. Patient 2 had two negative tests as well during the first week of hospital admission, first with cell-based assay with quantification by immunofluorescence (Associated Regional and University Pathologists) and second with cell-based assay with quantification by flow cytometry (Mayo Clinic Laboratories). Given test timing, use of cell-based assay, and multiple data points, we have no evidence that MOG antibody-associated disease was the etiology in these cases.